Discover how a new irreversible HER2 inhibitor acts as a precision weapon against cancer cells while sparing healthy tissue
Discover how RIG-I protein downregulates HER2 through the PI3K/Akt pathway in ovarian cancer cells, offering new therapeutic possibilities.